Potential Patient-Reported Toxicities With Disulfiram Treatment in Late Disseminated Lyme Disease
Recently, disulfiram has been proposed as a promising treatment for people suffering from persistent symptoms of Lyme Disease. Disulfiram has several distinct molecular targets. The most well-known is alcohol dehydrogenase, a key enzyme for detoxifying the organism after alcohol ingestion. Other tar...
Main Authors: | Alain Trautmann, Hugues Gascan, Raouf Ghozzi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2020.00133/full |
Similar Items
-
Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases
by: Kenneth B. Liegner
Published: (2019-05-01) -
“Repurposing” Disulfiram in the Treatment of Lyme Disease and Babesiosis: Retrospective Review of First 3 Years’ Experience in One Medical Practice
by: Jiachen Gao, et al.
Published: (2020-12-01) -
Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
by: Vinodh Kannappan, et al.
Published: (2021-09-01) -
Disulfiram-induced psychosis at a therapeutic dose and in clear sensorium: Two case demonstrations
by: Abhishek Ghosh, et al.
Published: (2019-01-01) -
Repurposing Disulfiram (Tetraethylthiuram Disulfide) as a Potential Drug Candidate against <i>Borrelia burgdorferi</i> In Vitro and In Vivo
by: Hari-Hara S. K. Potula, et al.
Published: (2020-09-01)